课题基金 / 基金详情

Effects Of Nicotine And Smoking On Cognitive Function

Effects Of Nicotine And Smoking On Cognitive Function
尼古丁和吸烟对认知功能的影响
批准号:
6535677
负责人:
Stephen J. Heishman
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Stephen J. Heishman的其他基金

相关文献

中文摘要
翻译
许多吸烟者报告说,吸烟可以帮助他们保持警觉,提高注意力。但是,吸烟是否会给吸烟者带来普遍的认知优势,还是因为尼古丁可以逆转短暂(两次吸烟之间)或长时间(一夜)戒烟造成的短暂认知缺陷,吸烟者会觉得自己的表现得到了提升?我们在这一领域的研究试图回答这个基本问题:吸烟或尼古丁是如何影响人类认知的?在几项研究中,我们证明了戒烟会损害认知功能,一般来说,吸烟或尼古丁会将这种缺陷逆转到吸烟的基线水平。这些数据有力地表明,这是维持尼古丁依赖个体吸烟的一种机制。然而,对于吸烟者来说,确定吸烟或尼古丁是否真的能增强认知能力,而不仅仅是提供戒断症状的缓解,是很困难的。因此,我们对非吸烟者进行了两项研究。在第一项研究中,我们给不吸烟者服用尼古丁口香糖(0,2,4毫克)。在第二项研究中,我们连续8天给不吸烟者服用尼古丁口香糖(0、2、4、8毫克)。两项研究的数据都一致发现尼古丁没有增强认知能力的作用。这些数据不支持尼古丁诱导的认知增强有助于在尼古丁依赖的早期阶段加强烟草使用的假设。我们也开始探索在认知测试中激活的大脑区域以及尼古丁对大脑激活的影响。大脑对药物或认知测试的反应可以从绘图研究中获得,其中通过PET测量区域脑血流量(rCBF)来推断功能。在我们的第一项研究中,我们在一项工作记忆测试中测量了吸烟者的认知激活情况,戒烟12小时的吸烟者和戒烟者分为两组,间隔一周。在一个阶段,受试者服用安慰剂口香糖,在另一个阶段,他们在进行记忆测试和脑部扫描之前服用4毫克尼古丁口香糖。双背测试包括一系列单独呈现的字母,目标字母是那些与该系列中的两个字母相匹配的字母。与安慰剂相比,尼古丁减少了吸烟者在双背测试中的错误,但对戒烟者的测试表现没有影响。双背测试激活的大脑区域与文献报道的一致:背外侧前额叶皮层、前扣带回和下顶叶皮层。然而,在安慰剂条件下,戒烟者的rCBF激活主要在左半球,而吸烟者的rCBF激活主要在右半球,这表明不同的认知策略。当给予尼古丁时,戒烟者的rCBF激活增强,但吸烟者的rCBF激活降低,这可能反映了慢性耐受性。
英文摘要
Many cigarette smokers report that smoking helps them stay alert and improves their concentration. But does tobacco use confer a general cognitive advantage to smokers or do smokers perceive a boost in performance because nicotine can reverse transient cognitive deficits due to brief (between cigarettes) or prolonged (overnight) periods of tobacco abstinence? Our research in this area has attempted to answer this fundamental question: how does smoking or nicotine affect human cognition? In several studies, we demonstrated that tobacco abstinence can impair cognitive functioning and that, in general, smoking or nicotine reverses such deficits to smoking baseline levels. These data strongly suggest that this is one mechanism that functions to maintain smoking in nicotine-dependent individuals. However, determining whether smoking or nicotine can truly enhance cognition, rather than simply provide withdrawal relief, can be difficult in smokers. Thus, we conducted two studies with nonsmokers. In the first study, we administered nicotine gum (0, 2, 4 mg) to nonsmokers during a single session. In the second study, we administered nicotine gum (0, 2, 4, 8 mg) to nonsmokers for 8 consecutive days. The data from both studies were consistent in finding no cognitive enhancing effects of nicotine. The data do not support the hypothesis that nicotine-induced cognitive enhancement contributes to the reinforcing effects of tobacco use during the early stages of nicotine dependence. We have also begun to explore the brain regions activated during performance of cognitive tests and the effect of nicotine on brain activation. The brain's response to a drug or cognitive test can be obtained from mapping studies in which measurement of regional cerebral blood flow (rCBF) via PET is used to infer function. In our first study, we measured cognitive activation during a working memory test in smokers, who abstained from smoking for 12 hours, and ex-smokers in two sessions, separated by one week. At one session, subjects received placebo gum, and at the other session, they received 4 mg nicotine gum before performing the memory test and the brain scan. The two-back test involved a series of letters presented individually, and target letters were those that matched a letter two back in the series. Compared to placebo, nicotine reduced errors on the two-back test in smokers, but had no effect on test performance in ex-smokers. The brain regions activated by the two-back test were consistent with those reported in the literature: dorsolateral prefrontal cortex, anterior cingulate gyrus, and inferior parietal cortex. However, in the placebo condition, rCBF activation in the ex-smokers predominated in the left hemisphere, and in smokers in the right hemisphere, suggesting differing cognitive strategies. When nicotine was administered, rCBF activation was enhanced in ex-smokers, but reduced in smokers, perhaps reflecting chronic tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF A NEW PSYCHOMETRIC INSTRUMENT FOR ASSESSING DRUG CRAVINGS
  • 批准号:
    6289578
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Stephen J. Heishman
  • 依托单位:
Effects Of Nicotine And Smoking On Cognitive Function
  • 批准号:
    6830649
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Stephen J. Heishman
  • 依托单位:
BEHAVIORAL MECHANISMS OF DRUG EFFECTS
  • 批准号:
    6431937
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Stephen J. Heishman
  • 依托单位:
Effect of nicotine on elements of attention in smokers and nonsmokers
  • 批准号:
    7733816
  • 项目类别:
  • 资助金额:
    $56.41万
  • 财政年份:
    --
  • 负责人:
    Stephen J. Heishman
  • 依托单位: